These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 32149769)

  • 1. Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model.
    Fan HH; Wang LQ; Liu WL; An XP; Liu ZD; He XQ; Song LH; Tong YG
    Chin Med J (Engl); 2020 May; 133(9):1051-1056. PubMed ID: 32149769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2
    Weston S; Coleman CM; Haupt R; Logue J; Matthews K; Li Y; Reyes HM; Weiss SR; Frieman MB
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32817221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of significant neutralizing antibodies against SARS-CoV-2 by a highly attenuated pangolin coronavirus variant with a 104nt deletion at the 3'-UTR.
    Lu S; Luo S; Liu C; Li M; An X; Li M; Hou J; Fan H; Mao P; Tong Y; Song L
    Emerg Microbes Infect; 2023 Dec; 12(1):2151383. PubMed ID: 36453209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective.
    Hosoki K; Chakraborty A; Sur S
    J Allergy Clin Immunol; 2020 Aug; 146(2):285-299. PubMed ID: 32624257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A global treatments for coronaviruses including COVID-19.
    Yousefi B; Valizadeh S; Ghaffari H; Vahedi A; Karbalaei M; Eslami M
    J Cell Physiol; 2020 Dec; 235(12):9133-9142. PubMed ID: 32394467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Genetic Diagnostic Methods for Detection for Novel Coronavirus 2019(nCoV-2019) in Japan.
    Shirato K; Nao N; Katano H; Takayama I; Saito S; Kato F; Katoh H; Sakata M; Nakatsu Y; Mori Y; Kageyama T; Matsuyama S; Takeda M
    Jpn J Infect Dis; 2020 Jul; 73(4):304-307. PubMed ID: 32074516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suramin Inhibits SARS-CoV-2 Infection in Cell Culture by Interfering with Early Steps of the Replication Cycle.
    Salgado-Benvindo C; Thaler M; Tas A; Ogando NS; Bredenbeek PJ; Ninaber DK; Wang Y; Hiemstra PS; Snijder EJ; van Hemert MJ
    Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32513797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genetic sequence, origin, and diagnosis of SARS-CoV-2.
    Wang H; Li X; Li T; Zhang S; Wang L; Wu X; Liu J
    Eur J Clin Microbiol Infect Dis; 2020 Sep; 39(9):1629-1635. PubMed ID: 32333222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines.
    Liu X; Wang XJ
    J Genet Genomics; 2020 Feb; 47(2):119-121. PubMed ID: 32173287
    [No Abstract]   [Full Text] [Related]  

  • 10. N-glycoproteomic profiling revealing novel coronavirus therapeutic targets potentially involved in Cepharanthine's intervention.
    An W; Tian F; Li J; Chen J; Tong Y
    Med Nov Technol Devices; 2022 Dec; 16():100156. PubMed ID: 35879945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia.
    Chu DKW; Pan Y; Cheng SMS; Hui KPY; Krishnan P; Liu Y; Ng DYM; Wan CKC; Yang P; Wang Q; Peiris M; Poon LLM
    Clin Chem; 2020 Apr; 66(4):549-555. PubMed ID: 32031583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repurposing old drugs as antiviral agents for coronaviruses.
    Yang CW; Peng TT; Hsu HY; Lee YZ; Wu SH; Lin WH; Ke YY; Hsu TA; Yeh TK; Huang WZ; Lin JH; Sytwu HK; Chen CT; Lee SJ
    Biomed J; 2020 Aug; 43(4):368-374. PubMed ID: 32563698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-reaction of current available SARS-CoV-2 MAbs against the pangolin-origin coronavirus GX/P2V/2017.
    Jia Y; Niu S; Hu Y; Chai Y; Zheng A; Su C; Wu L; Han P; Han P; Lu D; Liu Z; Yan X; Tian D; Chen Z; Qi J; Tian WX; Wang Q; Gao GF
    Cell Rep; 2022 Dec; 41(11):111831. PubMed ID: 36493785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system.
    Yuan S; Chan JFW; Chik KKH; Chan CCY; Tsang JOL; Liang R; Cao J; Tang K; Chen LL; Wen K; Cai JP; Ye ZW; Lu G; Chu H; Jin DY; Yuen KY
    Pharmacol Res; 2020 Sep; 159():104960. PubMed ID: 32473310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances of therapeutic targets and potential drugs of COVID-19.
    Zhang W; Zhang P; Wang G; Cheng W; Chen J; Zhang X
    Pharmazie; 2020 May; 75(5):161-163. PubMed ID: 32393419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid random access detection of the novel SARS-coronavirus-2 (SARS-CoV-2, previously 2019-nCoV) using an open access protocol for the Panther Fusion.
    Cordes AK; Heim A
    J Clin Virol; 2020 Apr; 125():104305. PubMed ID: 32143123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Simplified Quantitative Real-Time PCR Assay for Monitoring SARS-CoV-2 Growth in Cell Culture.
    Shema Mugisha C; Vuong HR; Puray-Chavez M; Bailey AL; Fox JM; Chen RE; Wessel AW; Scott JM; Harastani HH; Boon ACM; Shin H; Kutluay SB
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32878932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep Learning Based Drug Screening for Novel Coronavirus 2019-nCov.
    Zhang H; Saravanan KM; Yang Y; Hossain MT; Li J; Ren X; Pan Y; Wei Y
    Interdiscip Sci; 2020 Sep; 12(3):368-376. PubMed ID: 32488835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China.
    Kruse RL
    F1000Res; 2020; 9():72. PubMed ID: 32117569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.